SIMG
SUPN icon

Stephens Investment Management Group’s Supernus Pharmaceuticals SUPN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$49.8M Sell
1,581,093
-157,389
-9% -$4.96M 0.66% 59
2025
Q1
$56.9M Sell
1,738,482
-13,586
-0.8% -$445K 0.82% 45
2024
Q4
$63.4M Sell
1,752,068
-180,141
-9% -$6.51M 0.85% 43
2024
Q3
$60.2M Buy
1,932,209
+33,710
+2% +$1.05M 0.82% 48
2024
Q2
$50.8M Sell
1,898,499
-3,277
-0.2% -$87.7K 0.71% 58
2024
Q1
$64.9M Sell
1,901,776
-3,088
-0.2% -$105K 0.86% 45
2023
Q4
$55.1M Buy
1,904,864
+200,166
+12% +$5.79M 0.81% 56
2023
Q3
$47M Buy
1,704,698
+3,983
+0.2% +$110K 0.77% 58
2023
Q2
$51.1M Buy
1,700,715
+38,453
+2% +$1.16M 0.8% 58
2023
Q1
$60.2M Buy
1,662,262
+57,493
+4% +$2.08M 1.01% 35
2022
Q4
$57.6M Sell
1,604,769
-1,037
-0.1% -$37.2K 1.04% 29
2022
Q3
$54.4M Sell
1,605,806
-6,576
-0.4% -$223K 1.03% 24
2022
Q2
$46.6M Buy
1,612,382
+11,038
+0.7% +$319K 0.86% 47
2022
Q1
$51.8M Buy
1,601,344
+23,364
+1% +$755K 0.76% 59
2021
Q4
$46M Buy
1,577,980
+337,902
+27% +$9.85M 0.59% 83
2021
Q3
$33.1M Sell
1,240,078
-5,251
-0.4% -$140K 0.45% 98
2021
Q2
$38.3M Buy
1,245,329
+104,810
+9% +$3.23M 0.53% 92
2021
Q1
$29.9M Buy
1,140,519
+295,141
+35% +$7.73M 0.43% 103
2020
Q4
$21.3M Buy
845,378
+546,738
+183% +$13.8M 0.32% 112
2020
Q3
$6.22M Buy
298,640
+29,218
+11% +$609K 0.11% 148
2020
Q2
$6.4M Sell
269,422
-11,525
-4% -$274K 0.12% 140
2020
Q1
$5.05M Buy
280,947
+894
+0.3% +$16.1K 0.12% 136
2019
Q4
$6.64M Sell
280,053
-6,179
-2% -$147K 0.12% 138
2019
Q3
$7.87M Sell
286,232
-20,390
-7% -$560K 0.16% 132
2019
Q2
$10.1M Buy
306,622
+96,494
+46% +$3.19M 0.19% 130
2019
Q1
$7.36M Sell
210,128
-663
-0.3% -$23.2K 0.15% 138
2018
Q4
$7M Buy
210,791
+36,150
+21% +$1.2M 0.17% 138
2018
Q3
$8.79M Sell
174,641
-12,589
-7% -$634K 0.16% 138
2018
Q2
$10.9M Buy
187,230
+4,630
+3% +$270K 0.22% 130
2018
Q1
$8.36M Sell
182,600
-993
-0.5% -$45.5K 0.18% 135
2017
Q4
$7.32M Buy
+183,593
New +$7.32M 0.17% 142